We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+13.82%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.5B
AUM Growth
+$378M
Cap. Flow
+$252M
Cap. Flow %
1.74%
Top 10 Hldgs %
26.25%
Holding
735
New
61
Increased
261
Reduced
285
Closed
31

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$73.6M
2
GILD icon
Gilead Sciences
GILD
+$57M
3
MSFT icon
Microsoft
MSFT
+$44.1M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38.6M
5
NU icon
Nu Holdings
NU
+$38M

Sector Composition

Rank Sector Weight
1 Technology 30.32%
2 Healthcare 28.88%
3 Consumer Discretionary 8.63%
4 Financials 8.52%
5 Industrials 6.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTIS icon
126
Otis Worldwide
OTIS
$28B
$25.5M 0.18%
285,010
-36,698
-11% -$3.05M
PFE icon
127
Pfizer
PFE
$144B
$25.4M 0.18%
881,791
+180,002
+26% +$5.44M
FISV
128
Fiserv Inc
FISV
$28.9B
$25.2M 0.17%
189,960
+2,117
+1% +$260K
DXCM icon
129
DexCom
DXCM
$28.9B
$25.2M 0.17%
203,096
-116,247
-36% -$11.9M
CME icon
130
CME Group
CME
$93.5B
$24.9M 0.17%
118,352
+92,918
+365% +$19.8M
CCK icon
131
Crown Holdings
CCK
$13.2B
$24.7M 0.17%
268,246
+116,387
+77% +$9.87M
XENE icon
132
Xenon Pharmaceuticals
XENE
$6.28B
$24.5M 0.17%
530,884
-39,000
-7% -$1.38M
MTD icon
133
Mettler-Toledo International
MTD
$28.1B
$24.3M 0.17%
20,025
-416
-2% -$450K
HST icon
134
Host Hotels & Resorts
HST
$17.4B
$24.2M 0.17%
1,241,042
-160,467
-11% -$2.75M
WMS icon
135
Advanced Drainage Systems
WMS
$11.1B
$24M 0.17%
170,466
-134,216
-44% -$16.2M
URI icon
136
United Rentals
URI
$67.9B
$23.7M 0.16%
41,311
-9,642
-19% -$4.55M
ELV icon
137
Elevance Health
ELV
$83.7B
$23.6M 0.16%
50,088
+1,068
+2% +$494K
IBM icon
138
IBM
IBM
$214B
$23.6M 0.16%
144,334
+1,343
+0.9% +$203K
XOM icon
139
ExxonMobil
XOM
$634B
$23.4M 0.16%
234,460
-29,058
-11% -$3.05M
SLAB icon
140
Silicon Laboratories
SLAB
$7.17B
$23.4M 0.16%
176,863
+11,773
+7% +$1.29M
LW icon
141
Lamb Weston
LW
$7.51B
$23.4M 0.16%
216,233
+23,398
+12% +$2.25M
PGR icon
142
Progressive
PGR
$128B
$23.3M 0.16%
146,580
-28,392
-16% -$4.45M
AMP icon
143
Ameriprise Financial
AMP
$48.3B
$23.3M 0.16%
61,365
+40,040
+188% +$13.7M
SRE icon
144
Sempra
SRE
$59.2B
$23.2M 0.16%
310,188
+1,900
+0.6% +$136K
BMO icon
145
Bank of Montreal
BMO
$127B
$23.1M 0.16%
231,815
+137,898
+147% +$11.5M
EL icon
146
Estee Lauder
EL
$30.7B
$22.5M 0.16%
154,154
+31,939
+26% +$4.24M
BDX icon
147
Becton Dickinson
BDX
$45.8B
$22.5M 0.16%
92,427
-8,641
-9% -$2.13M
CYTK icon
148
Cytokinetics
CYTK
$10.8B
$22.3M 0.15%
267,240
-236,000
-47% -$8.55M
MCK icon
149
McKesson
MCK
$104B
$22.3M 0.15%
48,172
+11,081
+30% +$5.04M
DECK icon
150
Deckers Outdoor
DECK
$14.2B
$22.1M 0.15%
+198,264
New +$20.2M

Similar funds

Candriam SCA's Q4 2023 Portfolio in Review

As of Q4 2023, Candriam SCA held 735 positions worth $14.5B, up 2.7% from $14.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Candriam SCA's Q4 2023 filing shows 61 new, 261 increased, 285 reduced and 31 closed positions. Its largest new stake was Nu Holdings: 4,696,438 shares worth $39.1M. The largest sale was Seagen Inc. Common Stock, an estimated $112M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Candriam SCA's largest Q4 2023 buy was Nu Holdings: 4,696,438 shares worth $39.1M.
  • Candriam SCA added most to Visa in Q4 2023, an estimated $73.6M increase.
  • Candriam SCA's biggest Q4 2023 reduction was Royal Bank of Canada, cutting an estimated $44.3M.
  • Candriam SCA fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $112M.
  • Candriam SCA's ten largest holdings make up 26% of its $14.5B portfolio in Q4 2023.
  • Candriam SCA opened 61 new positions and closed 31 in Q4 2023.
  • Candriam SCA's portfolio value rose 2.7% quarter-over-quarter to $14.5B.

Based on Candriam SCA's 13F filing for Q4 2023, filed 14 Feb 2024.